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Only one third of older breast cancer survivors (BCS) meet national physical activity 
(PA) guidelines.  Theories of self-regulation and research with older adults suggest that 
executive function (EF) plays an important role in PA, yet the impact of lower EF on older 
survivors’ PA is unknown.  My project addressed this gap using secondary data from the 
Thinking and Living with Cancer (TLC) cohort study, which examined cognitive function 
among older BCS pre-treatment, followed every 12 months, and contemporaneously assessed 
matched controls.  My first aim was to test two hypotheses regarding EF change and PA and 
determine if these relationships differ between BCS and controls.  My hypotheses were: 1) EF 
decline from baseline to 12 months will predict lower PA at 24 months, and 2) lower PA at 12 
months will predict EF decline from 12 to 24 months.  My second aim was to explore whether 
the effects of EF change on PA in BCS differed based on risk factors for accelerated cognitive 
decline (i.e., older age, more advanced cancer stage, comorbidity, and APOE ε4 genotype).  The 
TLC study measured EF with neuropsychological tests and PA with the International Physical 
Activity Questionnaire-Short Form.  For aims 1 and 2, I used multiple regression with multiple 
imputation.  Primary results showed no significant effect of EF change from baseline to 12 
months on PA at 24 months (β=-0.01, p=0.88) and no significant group (BCS vs. controls) by EF 
interaction (β=-0.05, p=0.33).  Separate models in BCS and controls showed similar findings.  In 
the entire sample, PA at 12 months significantly predicted EF change from 12 to 24 months 
(β=0.17, p=0.01), but there was no significant group by PA interaction (β=-0.06, p=0.54).  
Separate analyses by group found a significant effect of PA for controls (β=0.07, p=0.02), but 
not for BCS (β=0.05, p=0.27).  Regarding the second aim, there were no significant interactions 
between EF change and the proposed risk factors on PA.  Findings were largely inconsistent with 
theory and prior research.  Continued research in this area will inform future exercise 
interventions to improve physical and cognitive health for the growing population of older 
cancer survivors.   
 
7 
CHAPTER 1. INTRODUCTION 
In the United States, female breast cancer survivors (BCS) aged 65 and older are among 
the largest groups of older cancer survivors, comprising an estimated 2.5 million women 
(American Cancer Society, 2019).  Due to advances in cancer treatment, 90% of BCS are living 
5 or more years after diagnosis (Howlader et al., 2019).  Although BCS’ increased longevity is 
encouraging, older cancer survivors are faced with increased risk of secondary malignancies, 
obesity, cardiovascular disease, diabetes, and accelerated functional decline (Bradshaw et al., 
2016; Cespedes Feliciano et al., 2017; Deimling, Arendt, Kypriotakis, & Bowman, 2009).  
Furthermore, many BCS’ quality of life and daily activities are substantially affected by 
persistent symptoms such as fatigue, pain, distress, and cognitive symptoms (Debess, Riis, 
Engebjerg, & Ewertz, 2010; Extermann et al., 2017; Janelsins et al., 2016).   
Longitudinal descriptive studies and intervention research have linked physical activity to 
reduced risk of secondary cancers, cardiovascular disease, and other chronic diseases as well as 
improved functional status in cancer survivors (Blair et al., 2014; Brown, Winters-Stone, Lee, & 
Schmitz, 2012; de Boer, Worner, Verlaan, & van Leeuwen, 2017; Jones et al., 2016).  
Additionally, randomized clinical trials have shown that physical activity can improve 
symptoms, mental health, and cognitive function in cancer survivors (Cormie, Nowak, 
Chambers, Galvao, & Newton, 2015; Daum, Cochrane, Fitzgerald, Johnson, & Buford, 2016; 
Schmitz et al., 2010; Sedjo et al., 2016).  Proposed physiological mechanisms for the effect of 
physical activity on survivors’ cognitive function include reduced systemic inflammation and 
greater neurogenesis facilitated by increased expression of neurotrophic and neuroprotective 
proteins (e.g., brain-derived neurotrophic factor, vascular endothelial growth factor, and insulin 
like growth factor) (Zimmer et al., 2016).  Despite the significant cognitive and health benefits of 
physical activity, only 33% of older cancer survivors meet national guidelines of 150 minutes of 
moderate or 75 minutes of vigorous intensity physical activity per week (Tarasenko, Chen, & 
Schoenberg, 2017), and 44% are sedentary (i.e., report no leisure time physical activity) 
(National Cancer Institute, 2019).  Although older cancer survivors and older adults in general 
show comparable levels of non-adherence to physical activity guidelines (National Cancer 
Institute, 2019; Tarasenko et al., 2017), older cancer survivors are understudied in physical 
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activity research; thus, predictors of their physical activity initiation and maintenance are largely 
unknown. 
Background 
 Low adherence to physical activity among older cancer survivors might be explained in 
part by difficulties with the executive domain of cognitive functioning.  Whereas physical 
activity shows promise for improving cognitive functioning in cancer survivors (Furmaniak, 
Menig, & Markes, 2016; Mustian, Sprod, Janelsins, Peppone, & Mohile, 2012), the effect of 
executive functioning on subsequent physical activity has not been examined in older cancer 
survivors.  However, in the general population of older adults, executive function and physical 
activity appear to have a bidirectional relationship (Best, Nagamatsu, & Liu-Ambrose, 2014; 
Daly, McMinn, & Allan, 2015).  In fact, one study of older adults found that over a six-year 
period, executive function predicted physical activity with 55% greater magnitude than the effect 
of physical activity on subsequent executive function (Daly et al., 2015).  Comparable or 
stronger relationships between executive function and subsequent physical activity may be 
expected in older BCS due to proposed accelerated aging effects of cancer and its treatment 
(Demark-Wahnefried, Morey, Sloane, Snyder, & Cohen, 2009; Mandelblatt et al., 2014).   
 A detrimental effect of lower executive functioning on older BCS’ physical activity is 
consistent with Self-Regulation Theories (Bandura, 2004, 2005; Hall & Fong, 2007, 2015).  
These theories posit that executive functioning is an important contributor to self-regulatory 
appraisals (e.g., self-efficacy, intentions) and behaviors (e.g., goal setting, planning) that 
facilitate health behaviors such as physical activity (Bandura, 2004; Hall & Fong, 2015).  Indeed, 
reduced executive functioning and global cognitive functioning have been associated with lower 
levels of physical activity, poor self-efficacy for physical activity, and functional decline among 
community-dwelling older adults (Best, Davis, & Liu-Ambrose, 2015; Gothe et al., 2014; Kim, 
2016; McAuley et al., 2011; McHugh & Lawlor, 2015; Rajan, Hebert, Scherr, Mendes de Leon, 
& Evans, 2015).  In older cancer survivors, self-regulation-based constructs (e.g., self-efficacy, 
intentions, planning) also appear to be associated with physical activity (Courneya et al., 2009; 
Craike, Gaskin, Mohebbi, Courneya, & Livingston, 2018; Karvinen et al., 2009; Morey et al., 
2015; Ottenbacher et al., 2011; Trinh, Plotnikoff, Rhodes, North, & Courneya, 2012; Ungar, 
Sieverding, Ulrich, & Wiskemann, 2015); however, research with older cancer survivors has not 
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yet examined relationships between executive function, self-regulatory appraisals and behaviors, 
and physical activity.   
 The impact of executive functioning on physical activity among older BCS may be 
similar to what has been found in the general population of older adults, or it may differ due to 
BCS’ unique challenges.  Cancer and its treatment appear to affect several cognitive domains, 
including executive function (Janelsins, Kesler, Ahles, & Morrow, 2014; Krolak, Collins, Weiss, 
Harris, & Van der Jagt, 2017), and lead to changes in the structure and function of frontal brain 
regions (i.e., areas associated with executive function) (Amidi et al., 2017; Chen et al., 2017; 
Deprez, Billiet, Sunaert, & Leemans, 2013; Kesler, Watson, & Blayney, 2015; McDonald & 
Saykin, 2013).  Additionally, cancer survivors are often faced with symptoms, side effects, and 
distress that have been associated with lower physical activity (Blair et al., 2014; Brown et al., 
2014; Courneya et al., 2009; Dunberger et al., 2013; Giacalone et al., 2013; Grov, Fossa, & Dahl, 
2011; Mosher et al., 2009; Sprod et al., 2012).  Theory suggests that executive function is needed 
for flexible thinking and problem solving to address such barriers to physical activity (Hofmann, 
Schmeichel, & Baddeley, 2012).  Therefore, older BCS may have an even greater need for 
executive functioning skills in order to overcome barriers to physical activity associated with 
cancer and its treatment. 
 The impact of executive functioning on physical activity may be particularly relevant for 
older cancer survivors, as older age is associated with lower global cognitive functioning among 
survivors (Janelsins et al., 2018; Jansen, Cooper, Dodd, & Miaskowski, 2011; Ono et al., 2015).  
Additionally, several biological factors may place certain older BCS at greater risk for cancer-
related cognitive impairment and lead to a greater impact of executive functioning on physical 
activity.  Having a more advanced cancer stage and greater than two comorbid medical 
conditions have been related to lower cognitive performance even prior to systemic cancer 
treatment (Ahles et al., 2008; Mandelblatt et al., 2014).  Additionally, emerging longitudinal 
evidence also suggests that BCS with one or more Apolipoprotein E (APOE) ε4 alleles (i.e., a 
genotype related to neurodegeneration) (Jagust, 2013) are more likely to show lowered cognitive 
performance after chemotherapy than BCS without an APOE ε4 allele (Ahles et al., 2003; 
Koleck et al., 2014; Mandelblatt et al., 2018).   
 These risk factors for accelerated cognitive decline may also be related to physical 
activity.  Indeed, older age and comorbidity are independently associated with lower physical 
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activity among cancer survivors (Lynch et al., 2016; Mora & Valencia, 2018).  These risk factors 
and advanced cancer stage may also relate to greater barriers to physical activity and fewer 
facilitators.  For example, social support is an important facilitator of physical activity among 
older adults (Lindsay Smith, Banting, Eime, O'Sullivan, & van Uffelen, 2017; Thornton et al., 
2017), and the risk for social isolation increases with older age (Iliffe et al., 2007).  Additionally, 
more advanced stage disease and greater medical comorbidity contribute to more severe somatic 
and psychological symptoms (e.g., fatigue, depression) (Hallet et al., 2019; Lie et al., 2015), 
which are barriers to physical activity among older cancer survivors (Hardcastle et al., 2018; 
Ottenbacher et al., 2011).  Although rates of sedentary lifestyles are similar among older adults 
regardless of APOE genotype (Fenesi et al., 2017; Tan et al., 2017), carrying at least one APOE 
ε4 allele appears to increase risk for cognitive decline (Ahles et al., 2003; Koleck et al., 2014; 
Mandelblatt et al., 2018).  Compensating for reduced facilitators and increased barriers to 
physical activity would theoretically require greater executive functioning skills (Hofmann et al., 
2012), and these skills could be lacking in those with risk factors for cognitive decline.  
Therefore, age, cancer stage, comorbidity, and APOE genotype should be explored as potential 
moderators of the relationship between executive function and physical activity among older 
BCS.   
The Present Study 
 The present study uses data from the Thinking and Living with Cancer (TLC) cohort 
study (R01CA129769, PI: Jeanne Mandelblatt), which is a prospective, multi-site study of older 
(i.e., aged 60 years and older) BCS and controls who are frequency matched for age, education, 
race, and geographic locale.  The TLC study is the only large prospective examination of 
objective cognitive function in older BCS assessed before systemic cancer therapy (pre-treatment 
baseline) and 12 and 24 months later as well as contemporaneously assessed controls.  To 
address gaps in the current understanding of the relationship between executive function and 
physical activity in older BCS, the present study addresses two specific aims: 
 Aim 1: To test two hypotheses regarding the association between executive function 




 Hypothesis 1: Executive function decline from baseline to 12 months will predict lower 
physical activity at 24 months. 
 This hypothesis is illustrated in Figure 1 and is based on Self-Regulation Theory 
(Bandura, 1991, 2004; Hall & Fong, 2007, 2015) and evidence from studies of older adults 
showing that better executive function predicts greater physical activity with moderate effect 
sizes (Best et al., 2014; Hall, Zehr, Paulitzki, & Rhodes, 2014; McAuley et al., 2011; Olson et 
al., 2017).   
 Hypothesis 2: Lower physical activity at 12 months will predict executive function 
decline from 12 to 24 months. 
 This hypothesis is also illustrated in Figure 1 and is based on strong evidence that 
physical activity can improve executive function in older adults (Albinet, Abou-Dest, Andre, & 
Audiffren, 2016; Anderson-Hanley, Arciero, Westen, Nimon, & Zimmerman, 2012; Baker et al., 
2010; Merom et al., 2016) and emerging evidence of this relationship in cancer survivors (Chan, 
McCarthy, Devenish, Sullivan, & Chan, 2015; Cormie et al., 2015; Furmaniak et al., 2016; 
Mustian et al., 2012).  Testing this hypothesis in older BCS builds the evidence base for the 
potential utility of physical activity to address executive difficulties associated with cancer and 
aging. 
 Aim 2: To explore whether the effects of executive function change on physical activity 
in BCS differ based on selected risk factors for accelerated cognitive decline (i.e., older age, 
more advanced cancer stage, comorbidity, and APOE ε4 genotype). 
This exploratory aim is based on evidence that these risk factors may affect cancer 
survivors’ cognitive function.  These risk factors are: older age, more advanced cancer stage (i.e., 
invasive disease), at least two comorbid medical conditions, and at least one APOE ε4 allele 
(Ahles et al., 2008; Ahles et al., 2003; Janelsins et al., 2018; Jansen et al., 2011; Koleck et al., 
2014; Mandelblatt et al., 2014; Ono et al., 2015).  Not only may these risk factors affect 
executive function, but they may be associated with increased barriers to physical activity, 
resulting in greater need for executive function in order to problem solve.  This may result in a 
stronger effect of executive function on physical activity among BCS with these risk factors.  
Conversely, executive function and physical activity may have greater range restriction among 
BCS with these risk factors.  This range restriction could decrease the strength of the relationship 
between executive function and physical activity.  Because the TLC study is the largest 
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prospective study of older BCS’ objective cognitive function to also examine these risk factors 
for accelerated cognitive decline, it presents a unique opportunity to explore their impact on the 
relationship between executive function and physical activity.  If exploratory tests show that 
older BCS with proposed risk factors experience stronger effects of executive function on 




CHAPTER 2. METHOD 
 This project examined data from the TLC study, a multi-site prospective longitudinal 
study of BCS aged 60 and older and matched healthy controls (R01CA129769).  Although 
recruitment and follow-up are ongoing for the TLC study, the current project used baseline and 
12- and 24-month post-baseline follow-up data from participants recruited between August 2010 
and December 2015.  Accrual sites included four academic and nine community practices in four 
regions of the U.S.: Los Angeles (City of Hope National Medical Center), New York area 
(Memorial Sloan-Kettering Cancer Center and community affiliates in New Jersey and Long 
Island), Tampa (Moffitt Cancer Center), and Washington, D.C. (Georgetown Lombardi 
Comprehensive Cancer Center and community sites in D.C., Maryland, Virginia, and New 
Jersey).  Indianapolis (Indiana University) was added as an accrual site after December 2015. 
The study protocol was approved by all institutional review boards and met HIPAA standards. 
Participants 
 Eligible BCS were female, aged 60 years and older, English speaking, and within 4-10 
weeks post-diagnosis of primary non-metastatic breast cancer (American Joint Committee on 
Cancer stages 0-III).  BCS were ineligible if they had ever had a stroke, moderate or severe 
traumatic brain injury, major psychiatric or neurodegenerative disorder, or within the last five 
years had another cancer diagnosis or systemic cancer treatment.  BCS were excluded at follow-
up if they experienced breast cancer recurrence or developed a new cancer or condition that 
rendered them ineligible (e.g., stroke).  Non-cancer controls were eligible if they met the same 
criteria as the BCS with the exception of a breast cancer diagnosis, and they were ineligible at 
follow-up for the same reasons as the BCS.  Controls were matched to BCS on age (within five 
years), race/ethnicity, education (<high school, high school to <college, college+), and 
geographic locale.  All participants received a $50 gift card per assessment. 
Procedure 
 The procedures for the TLC study have been published (Mandelblatt et al., 2018).  
Recruitment, informed consent, screening, and data collection are described briefly.  
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 BCS were recruited from medical oncology clinics at participating sites and enrolled after 
diagnosis and prior to systemic hormonal therapy or chemotherapy.  Controls consisted of 
friends of the BCS and community-recruited older adults.  Community recruitment involved 
outreach to senior centers and retirement communities, newsprint, and other media.  Of controls, 
24% were friends and 76% were community-recruited, and these groups showed comparable 
demographics.  Among the eligible BCS and controls, 36.2% of survivors and 97.6% of controls 
consented to participate (Figure 2).  Consent rates for BCS were 17.2% to 72.7% across study 
sites (median 62.5%), and the lowest consent rate occurred at a large urban cancer center with 
many competing research projects.  
 Participants provided written informed consent for each study component and were asked 
to provide a research proxy consent.  Those who declined to provide a research proxy consent 
were still able to participate.  After informed consent, participants were screened in-person or 
over the telephone using the Mini Mental State Examination (MMSE) (Folstein, Folstein, & 
McHugh, 1975) and the Wide Range Achievement Test, 4th edition (WRAT-4), a measure of 
word reading and a proxy for literacy and cognitive reserve (Manly, Schupf, Tang, & Stern, 
2005).  Those who scored ≤24 on the MMSE or <3rd grade level on the WRAT-4 were excluded, 
as this indicated that they may not have the ability to complete the study.  Participants were also 
ineligible if their performance on baseline cognitive tests were >3 standard deviations below 
normative values. 
 Baseline assessments for BCS were completed before systemic cancer therapy and after 
surgery, with the exception of seven BCS treated with neoadjuvant therapy who completed 
baseline prior to surgery and systemic cancer therapy.  Neuropsychological testing 
(approximately 55 minutes, completed in-person) and self-report measures (approximately 30-40 
minutes, completed either in-person, over the telephone, or via mail) were administered at 
baseline and yearly follow-up assessments.  Assessments were performed by trained research 
staff who completed certification for neuropsychological test administration every two years.  
Medical records were reviewed for BCS’ clinical data (e.g., diagnosis date, chemotherapy, 
hormonal therapy) at baseline and annually to determine eligibility for follow-up assessments 
(e.g., recurrence).  Blood specimens were collected from participants at baseline and processed 
and stored at -120°C.  Biospecimens were batch tested for Apolipoprotein E (APOE) genotype 
using TaqMan assays (rs429358 assay identifier: C_3084793-20; rs7412 assay identifier: 
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C_906973_10; Life Technologies, Carlsbad, CA) on a 7900HT Fast Real-Time PCR System 
(Thermo Fisher Scientific, Waltham, MA).  TaqMan Genotyper Software version 1.3 (Thermo 
Fisher Scientific) was used to complete group-blinded analyses.  Routine standards at the study 
biobank provided quality assurance for genetic testing.  
Measures 
Executive function 
The executive function domain was measured by computing the mean of six tests of 
cognitive abilities associated with executive function.  1) The Neuropsychological Assessment 
Battery (NAB) Digits Forward and 2) Digits Backward tested auditory attention and working 
memory (Stern & White, 2003).  Each of these tests included seven items, with two trials per 
item, in which the examinee repeated a series of digits forward or in reverse order with spans of 
3 to 9 digits.  3) The Trail Making Test Part A (TMT-A) and 4) Part B (TMT-B) from the 
Halstead-Reitan Neuropsychological Battery measured psychomotor speed, visual attention, and 
task switching (Reitan & Wolfson, 1985).  The examinee quickly connected numbers in order for 
TMT-A and alternated between numbers and letters in order for TMT-B.  5) The Digit Symbol-
Coding subtest of the Wechsler Adult Intelligence Test-III measured psychomotor speed, visual 
attention, and incidental learning and was also sensitive to general impairment (Lezak, 
Howieson, & Loring, 2004; Wechsler, 1997).  The examinee quickly associated symbols to 
numbers based on the corresponding number to symbol code.  6) The Controlled Oral Word 
Association Test (COWA) measured semantic knowledge, verbal fluency, and cognitive 
flexibility (Ruff, Light, Parker, & Levin, 1996).  This test included three, one-minute trials in 
which the examinee quickly generated words for each of the three letter cues. 
 The study team performed a factor analysis to confirm that the factor structure of this 
cognitive domain at baseline demonstrated substantial agreement (domain Cronbach’s α=.74) 
(Clapp et al., 2018).  Neuropsychological tests used to assess executive function in this study 
have established reliability and validity in diverse older adult populations and have been 
recommended by the International Cognition and Cancer Task Force (Wefel, Vardy, Ahles, & 
Schagen, 2011) or the National Alzheimer’s Coordinating Center’s Unified Data Set (Weintraub 
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et al., 2009).  Practice effects with multiple assessments were minimized by using alternate 
forms of the NAB (Stern & White, 2003).   
Physical activity 
Physical activity volume was measured with the 6-item International Physical Activity 
Questionnaire-Short Form (IPAQ-SF) that assessed vigorous and moderate activities and 
walking (i.e., light activity) during leisure and work over the past week (e.g., “During the last 7 
days, on how many days did you do vigorous physical activities like heavy lifting, digging, 
aerobics, or fast bicycling?” and “How much time did you usually spend doing vigorous physical 
activities on one of those days?”).  Days were multiplied by time (in minutes) and activities were 
weighted by Metabolic Equivalent of Tasks (MET) (vigorous=8, moderate=4, walking=3.3) to 
estimate the number of MET minutes per week (Craig et al., 2003).  MET minutes may be 
examined in three ways: (1) continuously, (2) grouped into high, moderate, and low volume 
categories, and (3) dichotomized as below or above the weekly guideline of 600 MET minutes 
per week (Craig et al., 2003).  IPAQ data have been found to moderately correlate with measures 
of physical fitness independent of Body Mass Index, which suggests that the IPAQ captures 
physiologically relevant activity (Minder et al., 2014).  Baseline physical activity was not 
included in primary analyses, as the majority of BCS had recently undergone surgery (mean time 
from surgery to baseline assessment=54.5 days, SD=51.3 days), and their reported physical 
activity would not accurately represent their normal activity. 
Age 
Collected during the baseline interview, age was considered a continuous moderator in 
aim 2.  
Cancer stage 
Collected during medical record review, cancer stage was dichotomized (i.e., stage 0 to I 
disease and stage II to III disease) at a cut point found to be clinically significant in published 




Medical comorbidities were assessed via participant self-report with a checklist of 25 
medical conditions (Mandelblatt et al., 2014).  Self-reported medical comorbidities have been 
found to be reliable and valid when compared to older adults’ medical records (Colditz et al., 
1986; Haapanen, Miilunpalo, Pasanen, Oja, & Vuori, 1997; Mandelblatt et al., 2001; Mandelblatt 
et al., 2010; Silliman & Lash, 1999).  The number of medical comorbidities was dichotomized 
(i.e., 0 or 1 and 2+) at a cut point found to be clinically significant in prior research with cancer 
samples (Deimling, Sterns, Bowman, & Kahana, 2007; Hewitt, Rowland, & Yancik, 2003; 
Mandelblatt et al., 2014) and considered a moderator in aim 2. 
APOE genotype 
Participants with any APOE ε4 allele were considered positive for the APOE ε4 
genotype, and this variable was considered a dichotomous (i.e., positive or negative) moderator 
in aim 2. 
Covariates 
Clinical (i.e., receipt of chemotherapy, number of days between surgery and the baseline 
assessment), demographic (i.e., age, education), and psychological factors (i.e., fatigue, 
depressive symptoms, anxiety) and baseline physical function were considered covariates.  
Covariates were determined a priori based on prior research indicating that these variables are 
associated with cognitive function and/or physical activity in older adults with and without breast 
cancer (Ahles et al., 2008; Blair et al., 2014; Demark-Wahnefried et al., 2009; Mandelblatt et al., 
2014; Ono et al., 2015).  Information regarding breast cancer and its treatment (e.g., diagnosis 
date, cancer stage, history of chemotherapy, hormonal therapy, radiation therapy, and dates of 
cancer treatments) was collected from medical records after enrollment by trained research staff 
at each study site.  Demographic information was collected during the baseline interview.  
Baseline physical function was measured with the physical component score of the 12-item 
Short-Form Health survey (SF-12) (Ware Jr, Kosinski, & Keller, 1996).  Psychological factors 
were assessed at baseline and during each follow-up.  Fatigue was measured with the 13-item 
Functional Assessment of Chronic Illness Therapy-Fatigue (Cella, 1998), depressive symptoms 
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with the 20-item Center for Epidemiologic Studies-Depression Scale (Radloff, 1977), and 
anxiety with the 20-item State-Trait Anxiety Inventory (Spielberger, 1983).  Each of these 
measures has demonstrated validity and reliability in cancer samples (Cella, Lai, Chang, 
Peterman, & Slavin, 2002; Hann, Winter, & Jacobsen, 1999; Schreier & Williams, 2004; Treanor 
& Donnelly, 2015).  
Data Analysis 
 Frequencies, means, and standard deviations were computed in SPSS (IBM SPSS 
Statistics for Windows, Version 25.0; Armonk, NY, USA) to characterize all study variables. 
Prior to the main analyses, all continuous variables were examined for normality (i.e., skewness 
<3.0 and/or kurtosis <8.0) and outliers (Kline, 2011).  The Loge transformation was employed 
for continuous MET minutes due to excessive skewness.  Preliminary data analyses also included 
paired-samples t-tests to compare BCS and healthy controls on demographics (i.e., age, 
education) and other covariates (i.e., depressive symptoms, anxiety, fatigue, physical function) in 
order to characterize the sample.  
Missing data 
Outcome data were coded for missingness (1=yes, 0=no) at 12- and 24-month follow-
ups.  Demographic and medical variables were used to predict missingness using logistic 
regression analysis.  Data were assumed to be missing at random (MAR), defined as systematic 
variance in missingness that is explained by observed data patterns.  Multiple imputation was 
employed prior to analytic models for aims 1 and 2 because this approach retains sample size by 
generating several plausible values for missing data based on a specified imputation model 
(Jakobsen, Gluud, Wetterslev, & Winkel, 2017; Rubin, 1996).  Therefore, the analyses with the 
whole sample, BCS, and controls were completed in two steps: 1) regression was used in the 
imputation models to create several imputed datasets, and 2) analytic models were then 
employed on each imputed dataset and parameter estimates were pooled.  Separate analytic 
models can be completed using data generated from an imputation model if all predictors in the 
analytic models are included in the imputation model along with auxiliary variables (Rubin, 
1996).  Demographic and medical variables significantly associated with missingness were 
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included in imputation models as auxiliary variables.  Participants with missing data at all three 
time points for either executive function or physical activity were excluded, as imputation 
models would not include prior levels of these variables as predictors.   
Separate imputation models were employed for the whole sample, BCS, and controls to 
include all predictors in analytic models for aims 1 and 2 (i.e., age, education, fatigue, 
depression, anxiety, physical function, physical activity, and executive function) along with 
identified auxiliary variables.  The imputation model for the whole sample also included the 
group variable (BCS or control) and interactions of group with executive function and physical 
activity at 12 months.  The imputation model for controls included the same predictors with the 
exception of group and interactions including group.  The imputation model for BCS also 
included covariates specific to BCS and additional predictors in the aim 2 analytic models: the 
receipt of chemotherapy, days between surgery and the baseline assessment, cancer stage 
(0=stage 0-1, 1=stage 2-3), baseline comorbidity (0=0-1 comorbid conditions, 1=≥2 comorbid 
conditions), APOE genotype (0=ε4 negative, 1=ε4 positive), and interactions of executive 
function at 12 months with age, cancer stage, comorbidity, and APOE genotype.  Arbitrary 
missing patterns and categorical variables were present in the whole sample, BCS, and controls; 
therefore, fully conditional specification imputation methods were employed in all imputation 
models with regression for continuous variables and logistic regression for binary and ordinal 
variables (van Buuren, 2007).   
Variable computation 
Executive function domain scores were the mean raw scores for the neuropsychological 
tests, and then z-scores were calculated based on the control mean and standard deviation at 
baseline.  Residualized change scores were calculated on executive function domain z-scores to 
represent change in executive function, as this method accounts for variance predicted by prior 
executive function (Cronbach & Furby, 1970).  Computation of residualized change scores was 
done by regressing executive function at 12 or 24 months on executive function at the prior time 
point (i.e., baseline or 12 months respectively) and then subtracting the predicted value from the 
observed value.   
Physical activity volume was examined continuously by the Loge of MET minutes per 
week in primary analyses, and sensitivity analyses included dichotomous (i.e., below or above 
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the guideline of 600 MET minutes per week) and categorical (i.e., high, moderate, and low 
intensity) self-reported physical activity.  Categorical physical activity is determined according 
to the IPAQ scoring algorithm (International Physical Activity Questionnaire, 2005).  Low 
activity volume is either no reported activity, or some activity that does not meet requirements 
for moderate or high intensity activity.  Moderate activity volume is either 1) three or more days 
of vigorous activity of at least 20 minutes per day, 2) five or more days of moderate intensity 
activity and/or walking at least 30 minutes per day, or 3) five or more days of any combination 
of walking, moderate, or vigorous intensity activities meeting a minimum of 600 MET minutes 
per week.  High activity volume is either 1) at least three days of vigorous intensity activity 
achieving at least 1500 MET minutes per week, or 2) seven of any combination of walking, 
moderate, or vigorous intensity activities achieving at least 3000 MET minutes per week.   
To improve interpretation of intercept estimates, continuous variables without a 
meaningful zero point (i.e., all continuous variables except the residualized change in executive 
function) were mean-centered.  Effect coding was used for the dichotomous group variable 
(BCS=1, control=-1) to reduce multicollinearity between the group predictor variable and the 
interaction between group and executive function/physical activity. 
Aim 1 
My primary aim was to test two hypotheses regarding the association between executive 
function change and physical activity and determine if these relationships differ between BCS 
and controls.  Hypothesis 1 is that executive function decline from baseline to 12 months will 
predict lower physical activity at 24 months.  Hypothesis 2 is that lower physical activity at 12 
months will predict executive function decline from 12 to 24 months.  These hypotheses were 
examined with two moderated multiple regression models with multiple imputation using SAS 
version 9.4 software (SAS Institute Inc., Cary NC).  Models included covariates (i.e., age, 
education, fatigue, depression, anxiety, physical function). Group (i.e., BCS or control) was the 
moderator variable in both models to determine if the relationships differed between older BCS 
and non-cancer controls.  The main effect of group was also assessed in both models.  The final 
analytic sample size for the primary analyses using multiple imputation included 320 BCS and 
323 controls.  A sensitivity power analysis in G*Power showed that with a two-tailed α=0.01 and 
N=643, there was 80% power to detect small main effects (f2=0.03) and moderate interaction 
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effects (f2=0.17) using multiple regression (Cohen, 1988).  Prior research with older adults has 
shown moderate effect sizes (βs=0.34 to 0.42) for the positive relationship between cognitive 
function and physical activity (Atkinson et al., 2010; Best et al., 2015; Daly et al., 2015).  
 Each hypothesis was also tested in BCS and controls separately with multiple regression 
using multiple imputation in SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).  Covariates 
for controls were the same as those included in the moderated models.  Covariates for BCS also 
included receipt of chemotherapy (0=hormone therapy only, 1=received chemotherapy and 
hormone therapy) and time between surgery and the baseline assessment in days.  Continuous 
physical activity was used for these models, and exploratory models included dichotomous and 
categorical physical activity.  Logistic regression was employed for analytic models predicting 
dichotomous physical activity, and proportional odds cumulative logit was employed to predict 
categorical physical activity. 
 Structural Equation Modeling (SEM) was also used as an omnibus test of the 
relationships between physical activity and executive function over time in grouped auto-
regressive cross-lagged (ARCL) models using full-information maximum likelihood estimation 
to account for missing data.  BCS or control was the grouping variable.  This approach deviates 
from the primary hypotheses, as it includes baseline physical activity.  Including baseline 
physical activity in the ARCL models allows for estimation of the covariance between baseline 
executive function and physical activity.  Without estimating and controlling for this covariance, 
the remaining parameter estimates may be inflated (Selig & Little, 2012).  Model fit was 
assessed holistically by a combination of the χ2 test, root mean square error of approximation 
(RMSEA ≤ 0.05 is good fit, ≤ 0.10 is adequate fit), comparative fit index (CFI ≥ 0.95 is 
acceptable fit), and Tucker Lewis index (TLI ≥ 0.95 is acceptable fit) (Byrne, 2012; Kline, 
2011).  Modification indices were considered when model fit was less than adequate.  When 
models were modified, the χ2 difference test (χ2(unmodified model) - χ2(modified model), 
df(unmodified model) - df(modified model)) was used to determine if the modified model fit was 
significantly improved relative to the unmodified model fit.  Then the standardized parameter 
estimates were examined to identify any statistically significant relationships between executive 
function and physical activity at baseline and 12- and 24-month follow-up.  ARCL models were 
examined with and without covariates (i.e., age, education, and baseline fatigue, depression, 




My secondary aim was to explore whether the effects of executive function change on 
physical activity in BCS differed based on selected risk factors for accelerated cognitive decline 
(i.e., older age, more advanced cancer stage, comorbidity, APOE ε4).  Each risk factor (i.e., age, 
cancer stage, comorbidity, and APOE genotype) was examined as a moderator in BCS using 
separate moderated multiple regressions.  Physical activity was measured continuously by the 
Loge of MET minutes per week.  Multiple imputation was employed to address missing data and 
covariates were included in regression models.  The Benjamini-Hochberg procedure was planned 
to reduce type I error due to the number of comparisons (B-H critical value=(i/m)Q=(rank of p-
value/4)0.05) (Benjamini & Hochberg, 1995).  There was not sufficient power to conduct 
definitive tests of moderation by risk factors among BCS; however, results can be used to plan 
for sufficient power in subsequent research. 
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CHAPTER 3. RESULTS 
Preliminary Analyses 
Demographics 
On average, participants were 68 years old, college educated, and had high average 
estimated cognitive reserve (Table 1).  Most were White non-Hispanic and did not have an 
APOE ε4 allele.  Chi-square and t-tests showed no significant differences between BCS and 
controls on age, years of education, cognitive reserve, race, ethnicity, or APOE genotype.  
Regarding clinical characteristics of BCS (Table 2), most had early stage disease (i.e., DCIS, 
Stage 1), received hormone therapy without chemotherapy, and had a mastectomy.  On average, 
BCS completed the baseline assessment approximately 2 months after surgery. 
Normality and outliers 
Descriptive statistics for main variables (i.e., executive function, physical activity, and 
covariates) were computed for BCS and controls (Table 3).  Continuous variables were examined 
for normality and outliers.  For BCS, days from surgery to baseline, depressive symptoms at 12 
months, and physical activity at 24 months (i.e., MET minutes per week) showed excessive 
kurtosis (i.e., >8.0).  Physical activity at 24 months also showed excessive skewness (i.e., >3.0) 
for BCS.  For controls, physical activity at 12 and 24 months showed excessive kurtosis.  All 
other variables showed adequate normality for BCS and controls.  One participant, a BCS, had 
extreme negative executive function scores at each time point (i.e., z<-3.5).  After excluding this 
participant, descriptive statistics and group comparisons on demographic information did not 
markedly change. 
Group comparisons 
Main study variables were compared between BCS and controls using t-tests and chi-
square tests.  T-tests showed that compared to controls, BCS had poorer executive function 
scores (t(613.90)=2.36, p<0.05, M(D)=0.13, SE(D)=0.05) and reported less physical activity in 
Log(e)MET minutes per week at baseline (t(590)=4.44, p<0.001, M(D)=0.41, SE(D)=0.09).  
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However, there were no significant differences in executive function scores or physical activity 
at 12 or 24 months (p>0.05).  Similarly, when examining categories of physical activity, BCS 
were more likely to report lower levels of activity at baseline (MET categorical score: 
χ2(2)=22.23, p<0.001; MET dichotomous score: χ2(1)=19.67, p<0.001), but this difference was 
no longer significant at 12 or 24 months (p>0.05).  BCS also reported greater baseline depressive 
symptoms (t(526.98)=-4.39, p<0.001, M(D)=-2.43, SE(M)=0.55) and anxiety (t(533.37)=-4.63, 
p<0.001, M(D)=-2.68, SE(D)=0.58), but these differences were no longer significant at 12 or 24 
months (p>0.05).  Additionally, BCS reported greater fatigue than controls at baseline 
(t(538.80)=5.30, p<0.001, M(D)=3.12, SE(D)=0.59) and 12 months (t(424.38)=3.34, p<0.001, 
M(D)=2.07, SE(D)=0.62), but this difference was no longer significant at 24 months (p>0.05).  
There were no significant differences between BCS and controls in physical function at any time 
point (p>0.05).  BCS and controls were not significantly different with respect to comorbidities 
at baseline, 12 months, or 24 months (p>0.05).  These comparisons did not markedly change 
after excluding the BCS outlier. 
Missingness 
Participants who at least partially completed 12- and 24-month follow-up assessments 
(i.e., completers) were compared to those who refused or were lost to follow-up (i.e., non-
completers).  In controls, t-tests showed that 12-month non-completers had fewer years of 
education (t(318)=-2.99, p<0.01, M(D)=-1.27, SE(D)=0.42) and lower cognitive reserve 
(t(318)=-2.14, p<0.05, M(D)=-6.53, SE(D)=3.04) than completers, and 24-month non-
completers had fewer years of education than completers (t(100.61)=-2.280, p<0.05).  The 
remaining t-tests for BCS and controls showed no significant differences between completers 
and non-completers on other demographics, main study variables, or covariates (p>0.05).  Chi-
square tests showed that for BCS and controls, 12- and 24-month completers and non-completers 
did not differ on race, ethnicity, APOE genotype, baseline medical comorbidities, or physical 
activity (i.e., dichotomous: <600 or ≥600 MET-minutes per week; categorical: low, moderate, 
high) at baseline or 12 months (p>0.05).  For BCS, there were no significant differences in 
cancer stage or treatment between 12- and 24-month completers and non-completers.  For 
controls, 24-month non-completers were more likely to report at least 2 comorbidities at 12 
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months than completers (χ2(1)=4.03, p<0.05).  These comparisons did not markedly change after 
excluding the BCS outlier. 
 The amount of missing data relative to the number of BCS and controls who completed 
each time point was computed (Table 3).  The greatest amount of missing data for BCS was 
found for physical activity at 24 months (14.2% missing).  For controls, the greatest amount of 
missing data was found for physical function at 24 months (8.8% missing).  Logistic regressions 
showed that missing executive function at 12 months was not significantly associated with 
covariates or baseline physical activity or executive function for controls.  BCS with more days 
between surgery and baseline were more likely to have missing data for 12 month executive 
function (OR=1.01, p<0.05) and physical activity (OR=1.01, p<0.05).  Controls with greater 
Log(e) transformed physical activity at baseline were less likely to have missing physical activity 
data at 12 months (OR=0.60, p<0.05).  BCS with higher baseline anxiety were less likely to have 
missing executive function data at 24 months (OR=0.87, p<0.05).  Missing physical activity data 
at 24 months were more likely for BCS with fewer years of education (OR=0.79, p<0.05), less 
than two medical comorbidities at baseline (OR=0.20, p<0.01), and at least two medical 
comorbidities at 12 months (OR=6.63, p<0.01).  Controls identifying as White Hispanic or non-
Hispanic were more likely to have missing 24-month executive function (OR=2.85, p<0.05) and 
physical activity data (OR=2.73, p<0.05).  Ethnicity and APOE genotype were not significant 
predictors of executive function or physical activity missingness for BCS or controls.  Cancer 
stage and treatment type were not significant predictors of executive function or physical activity 
missingness for BCS.  These findings did not markedly change after excluding the BCS outlier. 
 Several variables were added to imputation models as auxiliary variables due to 
significant associations with missingness.  In the imputation models for the whole sample and for 
BCS, comorbidity at 12 months was added as an auxiliary variable.  For controls, cognitive 
reserve, race, and comorbidity at 12 months were added as auxiliary variables.  Due to the 
substantial amount of missing data (53.7% of the sample had incomplete data when considering 
all variables in planned analyses), and the recommendation to use a greater number of 
imputations than the proportion of the sample with incomplete data (White, Royston, & Wood, 





The relationship between executive function change from baseline to 12 months and 
physical activity at 24 months was examined with multiple regression, including baseline 
covariates, and using multiple imputation to address missing data.  Model 1 tested this 
relationship in the entire sample of BCS and controls and included main effects of Group (BCS 
or control) and executive function change and the interaction between these variables.  The main 
and interaction effects were not significant (Table 4).  Baseline physical function was the only 
significant covariate (β=0.17, p<0.01), such that better physical function at baseline was 
associated with greater physical activity at 24 months.  Results of separate regressions for BCS 
(Model 2) and controls (Model 3) showed similar findings, with a significant effect for baseline 
physical function in BCS only (β=0.22, p<0.01).  Intercepts were significant (p<0.01), which 
indicates that physical activity at 24 months was significantly different from zero when there was 
no residualized change in executive function and covariates were at their average level.   
 The relationship between physical activity at 12 months and executive function change 
from 12 to 24 months was also examined with multiple regression, including baseline covariates, 
and using multiple imputation to address missing data.  Model 4 tested this relationship in the 
entire sample and included main effects of Group (BCS or control) and physical activity and the 
interaction between these variables.  Whereas the Group effect and Group x physical activity 
interaction were not significant (Table 5), there was a significant positive effect for physical 
activity (β=0.17, p=0.01), such that greater physical activity at 12 months was associated with 
increased executive function from 12 to 24 months.  Significant covariates were age (β=-0.15, 
p<0.01), education (β=0.11, p=0.02), and physical function (β=-0.11, p=0.03) such that younger 
age, higher education, and lower baseline physical function were associated with increased 
executive function at 24 months.  Results of separate regressions showed no significant effects of 
covariates or physical activity on executive function change for BCS.  However, there was a 
trend for a significant effect of age (β=-0.07, p=0.08).  For controls, there was a significant 
positive effect of physical activity on executive function change (β=0.07, p=0.02), and 
significant covariates were age (β=-0.07, p=0.01) and physical function (β=-0.07, p=0.04).  




Moderated multiple regression was used to explore potential moderators (i.e., age, cancer 
stage, comorbidity, APOE genotype) of the relationship between executive function change from 
baseline to 12 months and physical activity at 24 months.  Models included covariates and used 
multiple imputation to address missing data.  Results of these models are reported in Table 6.  In 
each model, effects of executive function, the potential moderator, and the interaction between 
these variables were not significant.  Baseline physical function was the only significant 
covariate in each of the models (Model 7: β=0.22, p<0.01; Model 8: β=0.22, p<0.01; Model 9: 
β=0.18, p=0.02; Model 10: β=0.21, p<0.01), such that better baseline physical function was 
associated with greater physical activity at 24 months.  Intercepts for each of the models were 
also significant (p≤0.01), indicating that at average levels of age, education, fatigue, depression, 
anxiety, physical function, and time since surgery, and for BCS who did not receive 
chemotherapy, physical activity significantly differed from zero when there was no change in 
executive function.  The Benjamini-Hochberg procedure was not necessary given the lack of 
significant moderation effects. 
Secondary Analyses 
Dichotomous physical activity 
Logistic regression with multiple imputation was used to examine the effect of executive 
function change from baseline to 12 months on dichotomous physical activity at 24 months 
(0=less than 600 MET minutes per week, 1=greater than 600 MET minutes per week).  Model 11 
tested this relationship in the entire sample and included main effects of Group (BCS or control) 
and executive function change and the interaction between these variables.  None of these effects 
were statistically significant (Table 7).  Physical function was a significant covariate (β=0.32, 
OR=1.05, p=0.01), such that better physical function at baseline was associated with a 5% 
greater odds of meeting guidelines for volume of physical activity at 24 months.  There was a 
non-significant trend for an effect of age (β=-0.19, p=0.09).  Results of separate logistic 
regressions showed no significant effects of executive function on dichotomous physical activity 
for BCS (Model 12) or controls (Model 13), and there were no significant covariates for controls.  
For BCS, physical function was a significant covariate (β=0.47, OR=1.07, p=0.01).  Significant 
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intercepts for all three models (p<0.01) indicate that physical activity was significantly greater 
than zero when there was no residualized change in executive function and other covariates were 
at their average level.  
 The relationship between dichotomous physical activity at 12 months and executive 
function change from 12 to 24 months was examined with multiple regression using multiple 
imputation.  Model 14 tested this relationship in the entire sample of BCS and controls and 
included main effects of Group (BCS or control) and physical activity and the interaction 
between these variables.  None of these effects were statistically significant (Table 8).  
Significant covariates were age (β=-0.15, p<0.01) and education (β=0.10, p=0.03), such that 
younger age and higher education were associated with increased executive function at 24 
months.  There was a non-significant trend for worse baseline physical function to be associated 
with increased executive function (β=-0.09, p=0.07).   
These relationships were also tested in separate models for BCS and controls. There were 
no significant effects of main variables or covariates for BCS (Model 15), although there was a 
non-significant trend for age (β=-0.07, p=0.07).  Among controls (Model 16), age was a 
significant covariate (β=-0.07, p=0.02), and there were non-significant trends for fatigue (β=0.06, 
p=0.09), physical function (β=-0.06, p=0.06), and meeting physical activity guidelines (β=0.13, 
p=0.07). 
Categorical physical activity 
Proportional odds cumulative logit regressions with multiple imputation were used to 
examine the effect of executive function change from baseline to 12 months on categorical 
physical activity (i.e., low, moderate, and high) at 24 months.  Model 17 tested this relationship 
in the entire sample of BCS and controls and included main effects of Group (BCS or control) 
and executive function change and the interaction between these variables.  None of these effects 
were significant (Table 9).  Physical function was a significant covariate (β=0.31, OR=1.04, 
p<0.01), such that better physical function at baseline was associated with a 4% greater 
cumulative odds of high or moderate physical activity at 24 months.  Non-significant trends were 
found for age (β=-0.18, OR=0.97, p=0.08) and baseline fatigue (β=0.24, OR=1.03, p=0.06).   
Results of separate cumulative logit regressions showed no significant effects of 
executive function change on categorical physical activity for BCS (Model 18) or controls 
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(Model 19).  For BCS, physical function was a significant covariate (β=0.48, OR=1.07, p=0.01).  
For controls, age was a significant covariate (β=-0.30, OR=0.96, p=0.03), and there was a non-
significant trend for baseline depression (β=-0.29, OR=0.95, p=0.09).  In all three models, the 
intercepts were significant for high compared to low physical activity (Model 17: β=-0.87, 
OR=0.42 p<0.01; Model 18: β=-1.10, OR=0.33, p<0.01; Model 19: β=-0.68, OR=0.51, p<0.01) 
and for moderate compared to low activity (Model 17: β=1.19, OR=3.29, p<0.01; Model 18: 
β=1.15, OR=3.16, p<0.01; Model 19: β=1.31, OR=3.71, p<0.01).  This indicates that when all 
covariates were equal to their average, no change in executive function from baseline to 12 
months was associated with a greater probability of low than high physical activity at 24 months, 
and a greater probability of moderate than low physical activity at 24 months.  However, because 
there were not significant effects of executive function, these probabilities remained constant 
regardless of change in executive function.   
The relationship between categorical physical activity at 12 months and executive 
function change from 12 to 24 months was examined with multiple regression using multiple 
imputation.  Model 20 tested this relationship in the entire sample and included main effects of 
Group (BCS or control) and physical activity and the interaction between these variables.  The 
Group effect and its interaction with physical activity were not significant (Table 10); however, 
high physical activity was associated with increased executive function at 24 months compared 
to low physical activity (β=0.28, p=0.04).  Significant covariates were age (β=-0.15, p<0.01) and 
education (β=0.10, p=0.03), such that younger age and higher education were associated with 
increased executive function at 24 months.  There was a non-significant trend for worse baseline 
physical function to be associated with increased executive function (β=-0.10, p=0.06).  The 
intercept also showed a non-significant trend for low physical activity to be associated with 
decline in executive function when all other covariates were equal to their average (β=-0.17, 
p=0.07).   
These relationships were also tested in separate models for BCS and controls. There were 
no significant effects of physical activity or covariates for BCS (Model 21).  There was a non-
significant trend for age (β=-0.07, p=0.08).  In controls (Model 22), there was a significant effect 
for high compared to low physical activity (β=0.18, p=0.02), and age was a significant covariate 
(β=-0.07, p=0.03).  There were also non-significant trends for physical function (β=-0.06, 
p=0.06) and moderate compared to low physical activity (β=0.13, p=0.09).  The intercept also 
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showed a non-significant trend for low physical activity to be associated with lower executive 
function when all other covariates were equal to their average (β=-0.12, p=0.05).   
Structural equation modeling 
Grouped auto-regressive cross-lagged (ARCL) structural equation models tested the 
relationship between executive function and physical activity over time from baseline to 24-
month follow-up.  The first ARCL model tested the relationship between executive function and 
Loge transformed MET minutes of physical activity per week at baseline and 12 and 24 months.  
This model did not include covariates and was grouped into BCS or controls.  The model showed 
poor fit (χ2(8)=126.68, p<0.01, RMSEA=0.22, CFI=0.92, TLI=0.71).  The covariance between 
baseline and 24-month executive function was added to the model because modification indices 
(MI) indicated increased model fit by adding this parameter (BCS: MI=66.38, Controls: 
MI=28.28).  The modified model showed fair fit (χ2(6)=21.98, p<0.01, RMSEA=0.09, CFI=0.92, 
TLI=0.71), and the additional covariance in this model significantly improved the fit from the 
prior model (χ2(2)difference=104.70, p<0.01).  For both BCS and controls, the auto-regressive 
pathways were significant (see Table 11 and Figure 3), indicating that values of executive 
function were correlated over time as well as reports of physical activity.  For BCS, there were 
no statistically significant cross-lagged relationships between executive function and physical 
activity.  However, there were non-significant trends for relationships between lower baseline 
physical activity and higher 12-month executive function (β=-0.08, p<0.10) and between lower 
24-month physical activity and higher 24-month executive function (β=-0.09, p<0.10).  For 
controls, the only significant cross-lagged relationship was a positive association between 12-
month physical activity and 24-month executive function (β=0.09, p<0.05), consistent with 
hypothesis 2.  There was also a non-significant trend for baseline physical activity to be 
positively correlated with executive function (β=0.09, p<0.10).   
Two additional ARCL models were examined. The first removed the covariance between 
baseline and 24-month executive function and added covariates (i.e., age, education, and baseline 
fatigue, depression, anxiety, and physical function).  This model showed poor fit (χ2(8)=115.76, 
p<0.01, RMSEA=0.21, CFI=0.93, TLI=0.16).  The covariance between baseline and 24-month 
executive function was added to the model because MI indicated increased model fit by adding 
this parameter (BCS: MI=64.26, Controls: MI=28.02).  This model showed adequate fit 
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(χ2(6)=13.36, p=0.04, RMSEA=0.06, CFI=0.99, TLI=0.92), and the additional covariance in this 
model significantly improved the fit from the prior model (χ2(2) difference=102.40, p<0.01).  For 
both BCS and controls, the auto-regressive pathways were significant (see Table 12 and Figure 
4), indicating that values of executive function were correlated over time as well as reports of 
physical activity.  For BCS, the only significant cross-lagged relationship was an association 
between lower baseline physical activity and higher 12-month executive function (β=-0.12, 
p<0.01).  For controls, the only significant cross-lagged relationship was an association between 
greater 12-month physical activity and higher 24-month executive function (β=0.08, p<0.05).   
Exploring physical function covariate 
Because physical function appeared to be a consistently significant covariate in models 
predicting physical activity in BCS and executive function in controls, further exploratory 
analyses were indicated.  First, baseline physical function was dichotomized at the median score 
in BCS (median score: 54.81) and controls (median score: 55.08).  Second, separate t-tests in 
BCS and controls were conducted to explore differences in Loge transformed physical activity 
and executive function domain z-score at each time point between those with higher and lower 
baseline physical function.  Third, scatterplots with regression lines were used to explore 
physical activity and executive function over time by dichotomized baseline physical function.  
Physical activity appeared to increase over time in BCS and remain stable over time in controls 
(Figure 5).  Among BCS, those with lower baseline physical function reported significantly 
lower physical activity at baseline than those with higher baseline physical function (t(249.22)=-
4.15, mean difference=-0.55, p<0.001); this difference was a non-significant trend with respect 
to physical activity at 12 months (t(192)=-1.71, mean difference=-0.28, p=0.09) and 24 months 
(t(164)=-1.74, mean difference=-0.33, p=0.08).  Among controls, those with lower baseline 
physical function reported significantly lower physical activity at each time point than those with 
higher baseline physical function (baseline: t(321)=-3.58, mean difference=-0.44, p<0.001; 12 
months: t(285)=-3.21, mean difference=-0.37, p<0.01; 24 months: t(228)=-3.01, mean 
difference=-0.42, p<0.01) .   
Executive function appeared to increase over time in BCS and controls (Figure 6).   
Among BCS, those with lower baseline physical function had significantly lower executive 
function at baseline than those with higher baseline physical function (t(302)=-3.30, mean 
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difference=-0.28, p<0.01); this difference was a non-significant trend with respect to executive 
function at 12 months (t(184.14)=-1.82, mean difference=-0.18, p=0.07) and 24 months (t(194)=-
1.89, mean difference=-0.20, p=0.06).  Among controls, those with lower baseline physical 
function had significantly lower executive function at baseline than those with higher baseline 
physical function (t(311)=-2.43, mean difference=-0.17, p<0.05) and 12 months (t(281)=-2.08, 




CHAPTER 4. DISCUSSION 
The current project is a secondary data analysis of the TLC study, which is the largest 
cohort of older breast cancer survivors and matched healthy controls with objective measures of 
cognitive function prior to systemic cancer treatment and at yearly follow-up.  Older BCS are 
understudied in general, and little is known about their cognitive function and physical activity.  
The TLC study provided a unique opportunity to examine the prospective relationship between 
executive function and physical activity among older BCS and matched healthy controls.  Prior 
research has shown that physical activity may improve executive function in older adults 
(Albinet et al., 2016; Anderson-Hanley et al., 2012; Baker et al., 2010; McAuley et al., 2011; 
Olson et al., 2017) and cancer survivors (Furmaniak et al., 2016; Mustian et al., 2012); however, 
this research has not specifically focused on older cancer survivors.  In older adults without 
cancer, previous research has found a bidirectional relationship between executive function and 
physical activity (Buckley, Cohen, Kramer, McAuley, & Mullen, 2014; Daly et al., 2015).  In 
contrast to prior research, executive function did not predict physical activity in the current 
sample of older BCS or controls; however, physical activity was associated with executive 
function in controls.  These findings were consistent across analyses, although significance was 
attenuated when physical activity was dichotomous. 
The lack of evidence for an effect of executive function on physical activity is 
inconsistent with prior literature and theory.  Self-regulation theory and prior research in older 
adults suggest that lower executive function could have a negative impact on physical activity 
(Bandura, 2005; Buckley et al., 2014; Hall & Fong, 2007, 2015; McAuley et al., 2011; Olson et 
al., 2017).  According to self-regulation theories, executive difficulties may affect cognitive and 
emotional appraisals (e.g., by lowering self-efficacy) and interfere with self-regulatory behaviors 
(e.g., goal setting, planning) that facilitate physical activity behavior (Bandura, 1991, 2004, 
2005; Buckley et al., 2014; Hall & Fong, 2007, 2015).  The inconsistency of the present findings 
with theory might be due to reduced sensitivity of neuropsychological tests to subtle deficits in 
executive function.  The specificity of objective performance-based executive function tests is 
also questionable because they require additional cognitive abilities (e.g., attention, processing 
speed, incidental learning, semantic knowledge, verbal fluency) (Bryan & Luszcz, 2000).  Some 
have argued that a combination of self and informant behavior rating scales have better 
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ecological validity for executive function than performance-based measures (Isquith, Roth, & 
Gioia, 2013; McAlister & Schmitter-Edgecombe, 2016; Roth, Isquith, & Gioia, 2014).  
However, neuropsychological measures in this study are similar to those used in prior research 
that found effects of executive function on physical activity in older adults over similar periods 
of time (i.e., 1-2 years) (Daly et al., 2015; McAuley et al., 2011; Olson et al., 2017). 
Results may indicate that executive function did not affect physical activity for the 
current sample.  Participants in the TLC study were highly educated and appeared to have intact 
cognitive and physical function (Mandelblatt et al., 2018).  Furthermore, executive function 
showed only a small change over the study period in BCS and controls.  Additionally, adherence 
to national guidelines for physical activity was greater in the current sample (56.6% in BCS and 
76.8% in controls at baseline) than in prior research with older adults and older cancer survivors 
(National Cancer Institute, 2019; Tarasenko et al., 2017).  Results also showed demographic and 
medical differences between completers and non-completers of follow-ups and significant 
predictors of missing data.  Controls who completed follow-ups had more education, greater 
cognitive reserve, and were less likely to have two or more comorbidities than controls who did 
not complete follow-ups.  For BCS, missing data for executive function or physical activity were 
related to more time between surgery and baseline, lower baseline anxiety, less education, and 
greater comorbidities.  For controls, missing data for executive function or physical activity were 
more likely for participants identifying as White, and missing physical activity data were related 
to lower physical activity at a prior time point.  Although the statistical approach controlled for 
these factors to an extent, the sample’s characteristics may have contributed to null findings.   
Alternatively, the relationship between executive function abilities and reported physical 
activity may be complex.  One study of older adults found that lower executive function was 
significantly associated with both objective and subjective daily functional ability; however, the 
correlation between executive function and objective functional ability was significantly greater 
than the correlation between executive function and self-reported functional ability (Mitchell & 
Miller, 2008).  This may have been an effect of measurement method, or it may indicate low 
accuracy of self-reported functional ability (i.e., reduced insight).  Future research may 
determine if those with worse executive function and low insight overreport their physical 
activity to a greater degree than those with intact insight.   
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Regarding the second hypothesis, findings indicate that physical activity at 12 months 
was related to executive function at 24 months among older adults without cancer, but not older 
BCS.  Analyses with categorized physical activity showed that for controls, a high level of 
physical activity predicted increased executive functioning when compared to a low level 
physical activity.  This positive, small relationship between physical activity and executive 
function is consistent with that found in observational studies of older adults (Bixby et al., 2007; 
Blumenthal et al., 2017; Daly et al., 2015).  Although physical activity did not significantly 
predict executive function in BCS, the effect sizes in models with continuous physical activity 
are similar between BCS and controls.  This discrepancy may be due in part to a difference in 
statistical power, given the two additional covariates for BCS.  Of note, few studies with older 
adults or cancer survivors have prospectively examined the relationship between physical 
activity and cognitive function over a similar period of time (i.e., 6-24 months) without testing an 
intervention (Daly et al., 2015; Phillips, Lloyd, Awick, & McAuley, 2017).  Interventions have 
found small to moderate effects of physical activity on executive function in older adults 
(Ludyga, Gerber, Brand, Holsboer-Trachsler, & Puhse, 2016; Sanders, Hortobagyi, la Bastide-
van Gemert, van der Zee, & van Heuvelen, 2019) and cancer survivors (Myers, Erickson, 
Sereika, & Bender, 2018).  The clinical significance of the small effect of physical activity on 
executive function is currently unclear.  However, physical activity may be mitigating subtle 
cognitive decline due to aging and cancer treatments, and cancer survivors report that even subtle 
cognitive symptoms have a negative impact on their quality of life and functioning (Klemp et al., 
2018; Reid-Arndt, Hsieh, & Perry, 2010).  
In secondary analyses, lower baseline physical activity in BCS predicted higher executive 
function at 12 months.  This result should be interpreted with caution as baseline physical 
activity was measured after surgery, and these secondary models did not control for cancer 
treatment type and time since surgery because they were grouped by BCS or control.  
Furthermore, BCS reported significantly less physical activity and lower executive function at 
baseline than controls.  Significant group differences in physical activity and executive function 
at baseline but not at follow-up suggest that BCS might have experienced improvement to match 
controls by follow-up; however, attrition was greater for BCS than controls, which may have 
affected the findings.  The baseline differences may have been due to a combination of the 
biological effects of cancer, surgery, and symptoms and the psychological impact of a cancer 
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diagnosis—all of which could have dissipated over time.  Indeed, BCS showed greater 
symptoms of depression, anxiety, and fatigue compared to controls at baseline, and, with the 
exception of fatigue at 12 months, these differences were non-significant at follow-ups.   
Regarding the second aim, the null effect of executive function change on physical 
activity in BCS was consistent across age, cancer stage, comorbidity, and APOE ε4 genotype.  
Theoretically, the largely intact executive function in our sample could have been used to 
ameliorate effects of risk factors on barriers and facilitators for physical activity.  Additionally, 
the relatively small change in executive function from baseline to 12 months could have 
contributed to its null relationship with physical activity across subgroups of BCS.  Also of note, 
only 17% of BCS had the APOE ε4 genotype, which further limited statistical power.  
Physical activity in BCS was not related to age, cancer stage, comorbidity, or APOE ε4 
genotype.  Findings do not converge with prior research indicating that lower physical activity is 
associated with older age and greater comorbidity among older adults and cancer survivors 
(Lynch et al., 2016; Mora & Valencia, 2018), but converge with research indicating no 
difference in activity level between cancer survivors as a function of disease stage (Shin et al., 
2017) and between older adults with or without an APOE ε4 allele (Fenesi et al., 2017; Tan et al., 
2017).  The inconsistency of our findings with prior research may be due to greater than typical 
activity in the current sample of BCS.  The range of ages in the present study was also restricted, 
as this study targeted BCS over 60 years of age.  This sample may also have been better 
equipped to manage health-related barriers to physical activity due to protective factors.  Indeed, 
BCS in the TLC study were highly educated and recruited from academic cancer centers, which 
may indicate greater access to resources (Mandelblatt et al., 2018).  Furthermore, BCS missing 
physical activity data at 24 months had fewer years of education, less than two comorbidities at 
baseline, and at least two medical comorbidities at 12 months.  Therefore, sample characteristics 
and attrition may have led to an underestimation of the degree to which risk factors affect 
physical activity in the population of older BCS. 
Baseline physical function was a consistently significant covariate in models testing the 
relationship between executive function change from baseline to 12 months on physical activity 
at 24 months in the whole sample and in BCS; however, it was not a significant covariate in 
these models for controls.  Exploratory t-tests and graphs showed a stable higher level of 
physical activity over time for controls with higher as compared to lower baseline physical 
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function, whereas BCS with lower baseline physical function appeared to increase their physical 
activity over time to a greater degree than BCS with higher baseline physical function.  The 
moderate positive relationship between physical function and physical activity is well established 
for older adults and older cancer survivors (Daum et al., 2016; Gine-Garriga, Roque-Figuls, 
Coll-Planas, Sitja-Rabert, & Salva, 2014; Layne et al., 2017; Morey et al., 2015; Portegijs, 
Keskinen, Tsai, Rantanen, & Rantakokko, 2017).  Not only does physical activity appear to 
improve physical function (Daum et al., 2016; Gine-Garriga et al., 2014; Layne et al., 2017), but 
those with higher physical function are more likely to engage in physical activity (Morey et al., 
2015; Portegijs et al., 2017).  Additionally, physical function as reported by the SF-12 includes 
difficulties engaging in physical activities (e.g., accomplishing less in work or activities, 
limitations in climbing stairs), which could have substantial overlap with participants’ amount of 
physical activity.  The effects of similar measurement also may be relevant, as both constructs 
were self-reported.  The lack of a significant relationship between physical function and physical 
activity for controls is unclear and inconsistent with prior research in older adults (Gine-Garriga 
et al., 2014; Layne et al., 2017; Portegijs et al., 2017).  Controls had greater range and less 
missing data for baseline physical function compared to BCS, so it is less likely that range 
restriction and missing data for physical function affected this result.  In fact, covariates were 
largely unrelated to physical activity at 24 months in controls.  Because the sample reported 
greater activity than is typically found among older adults and older cancer survivors (National 
Cancer Institute, 2019; Tarasenko et al., 2017), standard predictors of physical activity may be 
less relevant for this sample.  Predictors of degrees of physical activity among active older adults 
requires further study.     
Baseline physical function was also a significant or trending covariate in models testing 
the relationship between physical activity at 12 months and executive function change from 12 to 
24 months in the whole sample and in controls; however, it was not a significant covariate in 
these models for BCS.  Whereas prior research with older adults found a positive bidirectional 
relationship between physical activity and executive function (Gale, Allerhand, Sayer, Cooper, & 
Deary, 2014), in the current study, better baseline physical function predicted lower executive 
function change from 12 to 24 months.  Prior findings from the TLC study showed that executive 
function improved over time for BCS and controls (Mandelblatt et al., 2018).  Furthermore, 
exploratory t-tests and graphs showed that controls with better baseline physical function had 
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stable executive function, whereas controls with worse baseline physical function appeared to 
have greater room for improvement in executive function over time.    
Strengths of the current project warrant mention.  The TLC study is the largest 
prospective, controlled study of cognitive performance in older BCS starting before systemic 
cancer treatment.  Recruiting BCS aged 60 years and older was also a strength because this large, 
understudied group may be at risk for cognitive symptoms due to potential accelerated aging 
from cancer and its treatment (Ahles, Root, & Ryan, 2012).  The sample was recruited from 
diverse regions of the U.S. and its racial and ethnic diversity is representative of American breast 
cancer survivors.  In addition, measures included objective cognitive performance and validated 
self-report questionnaires.   
Along with these strengths, several limitations should be noted.  First, there were 
measurement limitations.  Performance-based measures of executive function may not be 
sufficiently sensitive to detect subtle cognitive symptoms reported by cancer survivors and may 
not represent executive difficulties in daily life (Isquith et al., 2013; McAlister & Schmitter-
Edgecombe, 2016; Roth et al., 2014).  Additionally, self-reported physical activity is susceptible 
to over-estimation from social desirability and poor recall (Adams et al., 2005; Sallis & Saelens, 
2000).  Second, the study sample was generally well-educated, high functioning, and cognitively 
intact at baseline and primarily recruited from academic medical centers.  Also, the response rate 
among BCS (36% of eligible BCS consented to participate) was low compared to prior 
longitudinal research on cancer-related cognitive impairment (Jansen et al., 2011; Krolak et al., 
2017; Underwood et al., 2019).  Therefore, results may underestimate the prevalence and 
severity of cognitive difficulties and overestimate physical activity in the general population of 
older BCS.  Third, study attrition and missing data may have affected the results.  There were 
differences between those who did and did not complete follow-ups (e.g., lower education and 
cognitive reserve among non-completers), and there were significant predictors of missing data 
(e.g., lower baseline executive function and physical activity for BCS, lower baseline physical 
activity for controls).  Although the statistical approach controlled for these factors, a 
relationship between the values of the missing data and the prior values cannot be ruled out.  
Such a relationship would indicate that the data are missing not at random (MNAR), although 
this cannot be verified.  Fourth, despite the large sample, there was insufficient power to detect 
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significant interaction effects.  Finally, the current project consisted of post-hoc analyses, as the 
TLC study was not designed to address the aims of the current project.   
There are a number of important directions for future research on the relationship 
between executive function and physical activity among older cancer survivors.  First, multiple 
measures could be utilized, such as self and informant reported behavior rating scales (e.g., 
Behavior Rating Inventory of Executive Function, Dysexecutive Questionnaire, Frontal Systems 
Behavior Scale) in addition to performance-based measures of executive function and 
actigraphy.  Multiple methods of measurement are recommended to address the limitations of 
specific measures and provide a better estimate of latent constructs (Cole & Maxwell, 2003; 
Kline, 2011; Miyake et al., 2000).  Examining consistency between self and informant reported 
behavior rating scales and performance-based measures of executive function may also be a way 
to estimate insight into executive abilities.  Then researchers could determine whether executive 
function insight predicts greater consistency between actigraphy and self-reported physical 
activity.  Second, recruitment from multiple community-based sites may provide a more diverse 
and representative sample of older cancer survivors, especially with respect to socioeconomic 
status.  Third, a theoretical model may be examined by including measures of cognitive and 
emotional appraisals and behavioral self-regulation that may mediate an effect of executive 
function on physical activity.  This study could also identify protective factors that may buffer 
the effect of executive function decline on physical activity (e.g., high social support for physical 
activity, low symptoms, enjoyment of exercise, access to safe walking paths or gyms).  Finally, 
future research may examine whether executive function correlates with physical activity when 
older cancer survivors are attempting to change their activity, such as during an exercise 
intervention.     
In conclusion, the current project aimed to test whether change in executive function 
predicted physical activity, and whether physical activity predicted change in executive function 
in older cancer survivors and matched healthy controls.  The primary aim of this project was 
based on theory and research with older adults suggesting a bidirectional effect between 
executive function and physical activity (Bandura, 1991, 2004, 2005; Best et al., 2014; Daly et 
al., 2015; Hall & Fong, 2007, 2015).  In contrast to this research, current findings indicate that 
change in executive function from baseline to 12 months did not predict physical activity at 24 
months in BCS and controls.  However, physical activity at 12 months significantly predicted 
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increased executive function at 24 months, but only for controls.  In addition, the null effect of 
executive function change on physical activity in BCS did not differ based on selected risk 
factors for accelerated cognitive decline.  Although the study had several strengths, results 
should be interpreted with caution, given limitations in measurement, sampling biases, and 
attrition.  There are many potential directions for future research.  For example, multiple 
methods of measurement and community-based recruitment would address several limitations of 
the current project.  Further research is needed to determine whether the relationship between 
executive function and physical activity is bidirectional in older BCS and survivors of other 
cancers.  Examining this relationship and elucidating its mechanisms will inform the 
development of future exercise interventions to improve the physical and mental health and 













Characteristic n (%)a n (%)a t or χ2(df) p 
Age 
    Mean (SD) 
    Range 
    Missing  
 
68.09 (6.07) 










Years of Education 
    Mean (SD) 
    Range 
    Missing 
 
15.23 (2.17) 










WRATb standard score 
    Mean (SD) 
    Range 














    Black or African American 
    White 
    American Indian or Alaska Native 
    Asian 
    Multiracial or other 




















    Hispanic 
    Non-Hispanic 













APOE genotype  
    ε4+ 
    ε4- 
    Missing 
 
53 (16.6) 










Note.  BCS = Breast cancer survivors; WRAT = Wide Range Achievement Test, 4th edition, 
word reading subtest; APOE = apolipoprotein E.   
aUnless otherwise specified.   
bMean and standard deviation of standard score are 100 and 15, respectively.   
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Table 2  
Clinical Characteristics of Breast Cancer Survivors (N=320) 
Characteristic n (%) 
AJCC stage 
    0 (DCIS) 
    Stage 1 
    Stage 2 
    Stage 3 
    Unknown 









    Hormone and Chemotherapy 
    Hormone only 






    Lumpectomy with radiation 
    Lumpectomy only 
    Mastectomy 
    None 







Days from surgery to baseline 
    Mean (SD) 
    Range 
    Missing (%) 
 
48.53 (52.21) 
a-160 – 421b 
2 (0.01) 
Note.  AJCC = American Joint Commission on Cancer; DCIS = Ductal Carcinoma In Situ.     
aThere were seven cases that completed baseline before surgery because they were scheduled for 
neoadjuvant systemic therapy.   









Table 3  
Descriptive Statistics for Main Variables at Each Time Point 
 Baseline 12 months 24 months 












Executive function z-score      
    Mean (SD) 
    Range 




















    Mean  
    (SD) 
    Range 
































    Low, n (%) 
    Moderate, n (%) 
    High, n (%) 
































    <600, n (%)  
    ≥600, n (%) 


























    Mean (SD) 
    Range 


























    Mean (SD) 
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Table 3 continued 
STAI 
    Mean (SD) 
    Range 


























    Mean (SD) 
    Range 


























    0-1, n (%) 
    >2, n (%) 

























Note.  BCS = Breast cancer survivors; MET = Metabolic Equivalent of Task; SF-12 PCS = Short Form Health Survey-12 Physical 
Component Score; CES-D = Center for Epidemiologic Studies-Depression Scale; STAI = State Trait Anxiety Inventory; FACIT-F = 
Functional Assessment of Chronic Illness Therapy-Fatigue. 




Table 4  
Regression Parameter Estimates for Aim 1, Hypothesis 1  
 df B SE β t p 
Model 1a        
Intercept   786.09  7.07 0.06  0.00 128.01 <0.01* 
BCSb   976.14 -0.04 0.06 -0.03   -0.73 0.47 
Age   562.19 -0.01 0.01 -0.08   -1.58 0.11 
Education   549.73  0.01 0.03  0.03    0.52 0.60 
Fatigue    536.79  0.02 0.01  0.12    1.80   0.07† 
Depression   375.39 -0.01 0.01 -0.05   -0.62 0.53 
Anxiety   416.32  0.02 0.01  0.11    1.53 0.13 
Physical function   416.73  0.03 0.01  0.17    3.06 <0.01* 
Executive function   638.33 -0.02 0.15 -0.01   -0.16 0.88 
Executive function by BCSb 1076.50 -0.14 0.14 -0.05   -0.98 0.33 
Model 2c        
Intercept   582.94  7.00 0.11  0.00 66.53 <0.01* 
Age   568.73 -0.02 0.02 -0.12 -1.58 0.11 
Education   328.57  0.03 0.05  0.05  0.60 0.55 
Fatigue    364.50  0.02 0.01  0.17  1.66 0.10 
Depression   329.69  0.01 0.02  0.07  0.55 0.59 
Anxiety   245.73  0.02 0.02  0.12  1.00 0.32 
Physical function   643.88  0.04 0.01  0.22  3.11 <0.01* 
Received chemotherapy   529.27 -0.01 0.21 -0.01 -0.04 0.97 
Time since surgery   241.38  0.00 0.00  0.01  0.13 0.90 
Executive function    376.02 -0.28 0.23 -0.22 -1.22 0.22 
Model 3d        
Intercept 1060.00  7.13 0.07  0.00 97.07 <0.01* 
Age   871.25 -0.01 0.01 -0.06 -0.89 0.37 
Education   621.06  0.01 0.04  0.01  0.20 0.84 
Fatigue    847.07  0.01 0.02  0.08  0.91 0.37 
Depression   569.75 -0.03 0.02 -0.13 -1.38 0.17 
Anxiety   818.55  0.00 0.02  0.02  0.27 0.79 
Physical function   551.76  0.02 0.01  0.10  1.25 0.21 
Executive function   880.66  0.25 0.22  0.22  1.10 0.27 
Note.  BCS = Breast cancer survivor; SE = standard error. 
aModel 1: Hypothesis 1 tested in the whole sample – effect of executive function residualized change from baseline 
to 12 months on physical activity (Loge of Metabolic Equivalent of Task (MET) minutes per week) at 24 months.  
bBreast cancer survivor compared to control group.  
cModel 2: Hypothesis 1 tested in breast cancer survivors (BCS) – effect of executive function residualized change 
from baseline to 12 months on physical activity (Loge of MET minutes per week) at 24 months.  
dModel 3: Hypothesis 1 tested in controls – effect of executive function residualized change from baseline to 12 





Table 5  
Regression Parameter Estimates for Aim 1, Hypothesis 2 
 df B SE β t p 
Model 4a        
Intercept 1900000  0.00 0.02  0.00 -0.08 0.94 
BCSb 1007.30 -0.01 0.02 -0.04 -0.44 0.66 
Age 1260.90 -0.01 0.00 -0.15 -3.37 <0.01* 
Education   917.95  0.02 0.01  0.11  2.27   0.02* 
Fatigue    887.45  0.00 0.00  0.07  1.16 0.25 
Depression   949.27  0.00 0.00  0.04  0.58 0.56 
Anxiety   994.86 -0.01 0.00 -0.08 -1.30 0.20 
Physical function   973.99 -0.01 0.00 -0.11 -2.14   0.03* 
Physical activity   446.84  0.06 0.02  0.17  2.46   0.01* 
Physical activity by BCSb   502.17 -0.01 0.02 -0.06 -0.61 0.54 
Model 5c        
Intercept 3688.20  0.04 0.04  0.03  0.86 0.39 
Age   900.33 -0.01 0.01 -0.07 -1.78   0.08† 
Education   578.32  0.02 0.02  0.04  1.10 0.27 
Fatigue    419.71  0.00 0.01  0.03  0.59 0.56 
Depression   579.44  0.01 0.01  0.04  0.72 0.47 
Anxiety 1011.80 -0.01 0.01 -0.08 -1.60 0.11 
Physical function   761.83 -0.01 0.01 -0.05 -1.19 0.23 
Received chemotherapy   685.89 -0.11 0.09 -0.11 -1.30 0.19 
Time since surgery   311.53  0.00 0.00 -0.07 -1.60 0.11 
Physical activity   328.94  0.04 0.04  0.05  1.11 0.27 
Model 6d        
Intercept 2550000  0.00 0.02  0.00  0.00 1.00 
Age   734.31 -0.01 0.00 -0.07 -2.44   0.01* 
Education   716.96  0.02 0.01  0.05  1.68   0.09† 
Fatigue  1932.80  0.01 0.01  0.05  1.42 0.16 
Depression   888.83  0.00 0.01  0.01  0.27 0.79 
Anxiety 1277.50  0.00 0.01  0.00  0.12 0.90 
Physical function   663.39 -0.01 0.00 -0.07 -2.04   0.04* 
Physical activity   803.49  0.07 0.03  0.07  2.28   0.02* 
Note.  BCS = Breast cancer survivor; SE = standard error. 
aModel 4: Hypothesis 2 tested in the whole sample – effect of physical activity (Loge of 
Metabolic Equivalent of Task (MET) minutes per week) at 12 months on executive function 
residualized change from 12 to 24 months.  
bBreast cancer survivor compared to control group.  
cModel 5: Hypothesis 2 tested in BCS – effect of physical activity (Loge of MET minutes per 
week) at 12 months on executive function residualized change from 12 to 24 months.  
dModel 6: Hypothesis 2 tested in controls – effect of physical activity (Loge of MET minutes per 





Table 6  
Regression Parameter Estimates for Aim 2 in Breast Cancer Survivors 
 df B SE β t p 
Model 7a        
Intercept   602.12  7.01 0.11  0.00 66.14   0.01* 
Age   738.76 -0.02 0.02 -0.11 -1.54 0.12 
Education   330.25  0.03 0.05  0.05  0.61 0.54 
Fatigue    372.76  0.02 0.01  0.17  1.68   0.09† 
Depression   337.77  0.01 0.02  0.07  0.56 0.58 
Anxiety   248.21  0.02 0.02  0.12  0.99 0.32 
Physical function   667.18  0.04 0.01  0.22  3.10 <0.01* 
Received chemotherapy   526.07 -0.01 0.21 -0.01 -0.05 0.96 
Time since surgery   242.45  0.00 0.00  0.01  0.13 0.89 
Executive function   357.58 -0.29 0.24 -0.23 -1.21 0.23 
Executive function by Age   863.00  0.00 0.03  0.02  0.16 0.87 
Model 8b        
Intercept   460.46  7.00 0.13  0.00 55.32   0.01* 
Stage   507.94 -0.01 0.10 -0.01 -0.08 0.94 
Age   576.29 -0.02 0.02 -0.12 -1.59 0.11 
Education   333.32  0.03 0.05  0.05  0.60 0.55 
Fatigue    363.52  0.02 0.01  0.17  1.67 0.10 
Depression   331.68  0.01 0.02  0.07  0.55 0.58 
Anxiety   248.94  0.02 0.02  0.12  1.01 0.31 
Physical function   655.04  0.04 0.01  0.22  3.10 <0.01* 
Received chemotherapy   462.19  0.00 0.23  0.00 -0.02 0.98 
Time since surgery   243.93  0.00 0.00  0.01  0.12 0.91 
Executive function   407.88 -0.27 0.23 -0.22 -1.18 0.24 
Executive function by Stage  1122.20  0.05 0.19  0.04  0.26 0.79 
Model 9c       
Intercept   618.06  7.06 0.11  0.05 64.93 <0.01* 
Comorbidity   498.96 -0.18 0.10 -0.15 -1.82   0.07† 
Age   573.45 -0.02 0.02 -0.09 -1.25 0.21 
Education   325.64  0.03 0.05  0.05  0.57 0.57 
Fatigue    349.08  0.02 0.01  0.15  1.51 0.13 
Depression   318.23  0.01 0.02  0.07  0.55 0.58 
Anxiety   239.93  0.02 0.02  0.12  1.02 0.31 
Physical function   597.24  0.03 0.01  0.18  2.43   0.02* 
Received chemotherapy   524.35 -0.04 0.21 -0.03 -0.20 0.84 
Time since surgery   235.06  0.00 0.00  0.01  0.09 0.93 
Executive function   372.72 -0.26 0.24 -0.21 -1.12 0.26 






Table 6 continued 
Model 10d        
Intercept   455.04  7.09 0.13  0.07 54.89   0.01* 
APOE ε4   346.28  0.16 0.13  0.13  1.24 0.22 
Age   541.14 -0.03 0.02 -0.12 -1.64 0.10 
Education   318.57  0.04 0.05  0.06  0.78 0.43 
Fatigue    365.64  0.02 0.01  0.15  1.50 0.13 
Depression   332.15  0.01 0.02  0.05  0.37 0.71 
Anxiety   243.72  0.02 0.02  0.13  1.10 0.27 
Physical function   631.39  0.04 0.01  0.21  2.87 <0.01* 
Received chemotherapy   527.44  0.02 0.21  0.01  0.08 0.94 
Time since surgery   245.51  0.00 0.00  0.02  0.22 0.83 
Executive function   301.62 -0.33 0.32 -0.26 -1.03 0.30 
Executive function by APOE ε4   379.17 -0.10 0.30 -0.08 -0.35 0.73 
Note. SE = standard error; APOE = apolipoprotein E. 
aModel 7: Testing aim 2: To explore whether the effect of executive function residualized change 
from baseline to 12 months on physical activity (Loge of Metabolic Equivalent of Task (MET) 
minutes per week) at 24 months differs in breast cancer survivors based on proposed moderators. 
Moderator is age (i.e., interaction between executive function and age). 
bModel 8: Aim 2 – Moderator is stage of disease (i.e., 0-1 vs. 2-3).  
cModel 9: Aim 2 – Moderator is comorbidity (i.e., 0-1 vs. ≥2 comorbid medical conditions).  
dModel 10: Aim 2 – Moderator is APOE genotype (i.e., no APOE ε4 allele vs. at least one APOE 







Table 7  
Regression Parameter Estimates for Aim 1, Hypothesis 1 with Dichotomous Physical Activity 
 df B SE Exp(B) β t p 
Model 11a         
Intercept   878.51 -1.06 0.11 0.35  1.06  9.22 <0.01* 
BCSb 1210.70 -0.05 0.11 0.95 -0.05 -0.47 0.64 
Age   779.08 -0.03 0.02 0.97 -0.19 -1.72   0.09† 
Education   562.42  0.02 0.06 1.02  0.04  0.37 0.71 
Fatigue    723.83  0.02 0.02 1.02  0.17  1.20 0.23 
Depression   497.29 -0.01 0.03 0.99 -0.08 -0.43 0.67 
Anxiety   549.53  0.02 0.02 1.02  0.16  0.96 0.34 
Physical function   607.19  0.05 0.02 1.05  0.32  2.75   0.01* 
Executive function   771.13 -0.13 0.31 0.88 -0.05 -0.44 0.66 
Executive function by BCSb 1257.30 -0.03 0.28 0.97 -0.01 -0.09 0.92 
Model 12c         
Intercept   504.15  0.99 0.22 2.69  0.99  4.54 <0.01* 
Age   709.69 -0.05 0.03 0.95 -0.28 -1.63 0.10 
Education   500.52  0.05 0.08 1.05  0.10  0.57 0.57 
Fatigue    493.20  0.04 0.03 1.04  0.37  1.60 0.11 
Depression   527.49  0.03 0.04 1.03  0.22  0.74 0.46 
Anxiety   316.53  0.03 0.04 1.03  0.24  0.81 0.42 
Physical function   775.20  0.07 0.02 1.07  0.47  2.73   0.01* 
Received chemotherapy   609.67 -0.01 0.41 0.99 -0.01 -0.01 0.99 
Time since surgery   385.24  0.00 0.00 1.00  0.15  0.74 0.46 










Table 7 continued 
Model 13d         
Intercept 1698.30  1.13 0.15 3.10  1.13  7.39 <0.01* 
Age 1056.50 -0.02 0.02 0.98 -0.15 -1.00 0.32 
Education   868.77  0.02 0.07 1.02  0.05  0.28 0.78 
Fatigue  1094.10  0.00 0.03 1.00  0.01  0.04 0.97 
Depression   818.80 -0.05 0.04 0.95 -0.26 -1.31 0.19 
Anxiety 1277.60  0.00 0.03 1.00 -0.02 -0.08 0.93 
Physical function   693.57  0.03 0.02 1.03  0.19  1.13 0.26 
Executive function   979.78  0.12 0.47 1.13  0.12  0.25 0.80 
Note.  BCS = Breast cancer survivor; SE = standard error. 
aModel 11: Hypothesis 1 tested in the whole sample – effect of executive function residualized change from baseline to 12 months on 
dichotomous physical activity at 24 months (likelihood of meeting physical activity guidelines of at least 600 Metabolic Equivalent of 
Task (MET) minutes per week compared to not meeting them).  
bBreast cancer survivor compared to control group.  
cModel 12: Hypothesis 1 tested in BCS – effect of executive function residualized change from baseline to 12 months on dichotomous 
physical activity at 24 months.  
dModel 13: Hypothesis 1 tested in controls – effect of executive function residualized change from baseline to 12 months on 







Table 8  
Regression Parameter Estimates for Aim 1, Hypothesis 2 with Dichotomous Physical Activity 
 df B SE β t p 
Model 14a        
Intercept 4507.20 -0.02 0.02 -0.05 -1.04 0.30 
BCSb   916.75  0.00 0.03  0.00 -0.02 0.98 
Age 1298.50 -0.01 0.00 -0.15 -3.34 <0.01* 
Education   938.51  0.02 0.01  0.10  2.18   0.03* 
Fatigue    909.52  0.01 0.00  0.08  1.36 0.17 
Depression   929.37  0.00 0.00  0.04  0.53 0.60 
Anxiety   946.32  0.00 0.00 -0.07 -1.19 0.23 
Physical function 1021.80 -0.01 0.00 -0.09 -1.85   0.07† 
Meeting PA guidelinesc    565.54  0.04 0.03  0.09  1.57 0.12 
Meeting PA guidelinesc by BCSb   587.16 -0.02 0.03 -0.05 -0.79 0.43 
Model 15d        
Intercept   666.39 -0.01 0.07 -0.01 -0.14 0.89 
Age   923.46 -0.01 0.01 -0.07 -1.81   0.07† 
Education   583.23  0.02 0.02  0.04  1.05 0.29 
Fatigue    431.19  0.00 0.01  0.03  0.63 0.53 
Depression   578.16  0.01 0.01  0.04  0.68 0.50 
Anxiety 1017.30 -0.01 0.01 -0.07 -1.51 0.13 
Physical function   845.95 -0.01 0.01 -0.04 -1.06 0.29 
Received chemotherapy   689.59 -0.11 0.09 -0.11 -1.25 0.21 
Time since surgery   308.12  0.00 0.00 -0.07 -1.55 0.12 







Table 8 continued 
Model 16e        
Intercept 1131.60 -0.10 0.06 -0.10 -1.66 0.10 
Age   769.98 -0.01 0.00 -0.07 -2.37   0.02* 
Education   732.88  0.02 0.01  0.05  1.62 0.11 
Fatigue  2170.60  0.01 0.01  0.06  1.68   0.09† 
Depression   898.46  0.00 0.01  0.01  0.20 0.84 
Anxiety 1317.80  0.00 0.01  0.01  0.20 0.84 
Physical function   708.19 -0.01 0.00 -0.06 -1.91   0.06† 
Meeting PA guidelines   818.22  0.13 0.07  0.13  1.80   0.07† 
Note.  BCS = Breast cancer survivor; SE = standard error; PA = physical activity. 
aModel 14: Hypothesis 2 tested in the whole sample – effect of dichotomous physical activity at 12 months on executive function 
residualized change from 12 to 24 months (likelihood of meeting physical activity guidelines of at least 600 Metabolic Equivalent of 
Task (MET) minutes per week compared to not meeting them). 
bBreast cancer survivor compared to control group.  
cAt least 600 MET-minutes per week compared to less than 600 MET-minutes per week. 
dModel 15: Hypothesis 2 tested in BCS – effect of dichotomous physical activity at 12 months on executive function residualized 
change from 12 to 24 months.  
eModel 16: Hypothesis 2 tested in controls – effect of dichotomous physical activity at 12 months on executive function residualized 







Table 9  
Regression Parameter Estimates for Aim 1, Hypothesis 1 with Categorical Physical Activity 
 df B SE Exp(B) β t p 
Model 17a         
Intercept, High activity   878.60 -0.87 0.11 0.42 -0.87 -8.02 <0.01* 
Intercept, Moderate activity   827.59  1.19 0.12 3.29  1.19 10.12 <0.01* 
BCSb   949.60 -0.12 0.09 0.89 -0.12 -1.31 0.19 
Age   604.60 -0.03 0.02 0.97 -0.18 -1.76   0.08† 
Education   490.03  0.03 0.05 1.03  0.06  0.59 0.56 
Fatigue    659.95  0.03 0.02 1.03  0.24  1.91   0.06† 
Depression   595.12  0.00 0.02 1.00 -0.02 -0.13 0.90 
Anxiety   470.22  0.03 0.02 1.03  0.19  1.41 0.16 
Physical function   660.44  0.04 0.01 1.04  0.31  3.02 <0.01* 
Executive function 1151.20 -0.11 0.24 0.90 -0.04 -0.44 0.66 
Executive function by BCSb 2084.70 -0.23 0.22 0.79 -0.09 -1.04 0.30 
Model 18c         
Intercept, High activity   582.48 -1.10 0.20 0.33 -1.10 -5.56 <0.01* 
Intercept, Moderate activity   610.98  1.15 0.20 3.16  1.15  5.77 <0.01* 
Age   681.03 -0.01 0.02 0.99 -0.08 -0.57 0.57 
Education   461.10  0.10 0.07 1.11  0.22  1.49 0.14 
Fatigue    362.40  0.03 0.02 1.03  0.27  1.29 0.20 
Depression   421.52  0.02 0.03 1.02  0.18  0.73 0.47 
Anxiety   330.41  0.04 0.03 1.04  0.34  1.51 0.13 
Physical function   388.99  0.07 0.03 1.07  0.48  2.72   0.01* 
Received chemotherapy   384.14 -0.17 0.36 0.84 -0.17 -0.46 0.64 
Time since surgery   282.68  0.00 0.00 1.00  0.21  1.15 0.25 







Table 9 continued 
Model 19d         
Intercept, High activity 1230.50 -0.68 0.14 0.51 -0.68 -4.75 <0.01* 
Intercept, Moderate activity 1543.40  1.31 0.16 3.71  1.31  8.12 <0.01* 
Age   712.38 -0.04 0.02 0.96 -0.30 -2.17   0.03* 
Education   622.89 -0.03 0.06 0.97 -0.07 -0.53 0.60 
Fatigue    886.43  0.04 0.03 1.04  0.23  1.34 0.18 
Depression   966.54 -0.05 0.03 0.95 -0.29 -1.72   0.09† 
Anxiety 1198.50  0.02 0.03 1.02  0.11  0.71 0.48 
Physical function   836.59  0.02 0.02 1.02  0.18  1.23 0.22 
Executive function 1967.00  0.18 0.36 1.20  0.18  0.51 0.61 
Note.  BCS = Breast cancer survivor; SE = standard error. 
aModel 17: Hypothesis 1 tested in the whole sample – effect of executive function residualized change from baseline to 12 months on 
categorical (low, moderate, high) physical activity at 24 months.  
bBreast cancer survivor compared to control group.  
cModel 18: Hypothesis 1 tested in BCS – effect of executive function residualized change from baseline to 12 months on categorical 
(low, moderate, high) physical activity at 24 months. 
dModel 19: Hypothesis 1 tested in controls – effect of executive function residualized change from baseline to 12 months on 








Table 10  
Regression Parameter Estimates for Aim 1, Hypothesis 2 with Categorical Physical Activity 
 df B SE β t p 
Model 20a        
Intercept 1849.80 -0.08 0.04 -0.17 -1.83   0.07† 
BCSb 1006.60  0.01 0.05  0.03  0.30 0.77 
Age 1244.00 -0.01 0.00 -0.15 -3.21 <0.01* 
Education   919.10  0.02 0.01  0.10  2.17   0.03* 
Fatigue    983.87  0.01 0.00  0.08  1.31 0.19 
Depression   931.87  0.00 0.00  0.04  0.55 0.58 
Anxiety   954.12  0.00 0.00 -0.07 -1.17 0.24 
Physical function   883.81 -0.01 0.00 -0.10 -1.91   0.06† 
Moderate physical activity 1449.10  0.08 0.06  0.18  1.51 0.13 
High physical activity   866.26  0.13 0.06  0.28  2.10   0.04* 
Moderate physical activity by BCSb   951.77 -0.03 0.06 -0.05 -0.45 0.65 
High physical activity by BCSb   888.77 -0.04 0.06 -0.09 -0.70 0.48 
Model 21c        
Intercept   885.03 -0.02 0.07 -0.02 -0.21 0.83 
Age   993.06 -0.01 0.01 -0.07 -1.78   0.08† 
Education   595.60  0.02 0.02  0.04  1.02 0.31 
Fatigue    432.61  0.00 0.01  0.03  0.65 0.52 
Depression   567.80  0.01 0.01  0.04  0.66 0.51 
Anxiety 1001.00 -0.01 0.01 -0.07 -1.50 0.13 
Physical function   964.23 -0.01 0.01 -0.04 -1.14 0.26 
Received chemotherapy   711.44 -0.11 0.09 -0.11 -1.24 0.22 
Time since surgery   303.12  0.00 0.00 -0.07 -1.50 0.13 
Moderate physical activity   772.42  0.05 0.09  0.05  0.51 0.61 







Table 10 continued 
Model 22d        
Intercept 1713.60 -0.12 0.06 -0.12 -1.95   0.05† 
Age   775.56 -0.01 0.00 -0.07 -2.22   0.03* 
Education   723.22  0.02 0.01  0.05  1.63 0.10 
Fatigue  1990.90  0.01 0.01  0.05  1.55 0.12 
Depression   828.74  0.00 0.01  0.01  0.29 0.77 
Anxiety 1232.60  0.00 0.01  0.01  0.23 0.81 
Physical function   710.65 -0.01 0.00 -0.06 -1.91   0.06† 
Moderate physical activity 1236.10  0.13 0.07  0.13  1.68   0.09† 
High physical activity 1377.70  0.18 0.08  0.18  2.27   0.02* 
Note.  BCS = Breast cancer survivor; SE = standard error. 
aModel 20: Hypothesis 2 tested in the whole sample – effect of categorical physical activity (low, moderate, high) at 12 months on 
executive function residualized change from 12 to 24 months.  
bBreast cancer survivor compared to control group.  
cModel 21: Hypothesis 2 tested in BCS – effect of categorical physical activity (low, moderate, high) at 12 months on executive 
function residualized change from 12 to 24 months.  
dModel 22: Hypothesis 2 tested in controls – effect of categorical physical activity (low, moderate, high) at 12 months on executive 







Table 11  
Parameter Estimates for Grouped ARCL Model  
  
Baseline 12 Month 24 Month 
Group 
 
EF EF PA EF PA 
    Predictor β (SE) β (SE) β (SE) β (SE) β (SE) 
BCS 











    Baseline PA 0.07 (0.05) -0.08 (0.04)†     0.49 (0.05)** n/a n/a 
    12 Month EF n/a n/a n/a     0.29 (0.07)** 0.04 (0.07) 
    12 Month PA n/a 0.06 (0.07) n/a 0.04 (0.04)     0.55 (0.06)** 
    24 Month EF     0.76 (0.04)** n/a n/a n/a n/a 
    24 Month PA n/a n/a n/a  -0.09 (0.05)† n/a 
Control 











    Baseline PA   0.09 (0.05)† 0.04 (0.03)     0.43 (0.05)** n/a n/a 
    12 Month EF n/a n/a n/a     0.48 (0.06)** 0.01 (0.05) 
    12 Month PA n/a 0.00 (0.06) n/a   0.09 (0.04)*     0.63 (0.04)** 
    24 Month EF     0.56 (0.07)** n/a n/a n/a n/a 
    24 Month PA n/a n/a n/a -0.04 (0.06) n/a 
Note.  ARCL = autoregressive cross-lagged; EF = executive function; PA = physical activity; SE = standard error; BCS = Breast 
cancer survivor; n/a = not applicable. 
†p < 0.10.  
*p < 0.05.  





Table 12  
Parameter Estimates for Grouped ARCL Model with Covariates 
  
Baseline 12 Month 24 Month 
Group 
 
EF PA EF PA EF PA 
    Predictor β (SE) β (SE) β (SE) β (SE) β (SE) β (SE) 
BCS 






 0.79 (0.04)** 
 





    Baseline PA  0.01 (0.03) n/a -0.08 (0.03)**  0.47 (0.07)** n/a n/a 
    12 Month EF n/a n/a n/a n/a  0.29 (0.07)**  -0.10 (0.12) 
    12 Month PA n/a n/a  0.02 (0.03) n/a  0.02 (0.03)   0.52 (0.07)** 
    24 Month EF  0.28 (0.04)** n/a n/a n/a n/a n/a 
    24 Month PA n/a n/a n/a n/a -0.06 (0.03)† n/a 
    Age -0.04 (0.01)** -0.02 (0.01) -0.02 (0.01)**  0.00 (0.01) -0.04 (0.01)** -0.02 (0.01) 
    Education  0.08 (0.02)**  0.00 (0.03)  0.01 (0.01) -0.01 (0.03)  0.06 (0.02)**  0.03 (0.04) 
    Fatigue  0.00 (0.01)  0.02 (0.01)†  0.00 (0.01)  0.01 (0.01)  0.00 (0.01)  0.01 (0.01) 
    Depression -0.01 (0.01) -0.02 (0.01)  0.00 (0.01)  0.01 (0.02)  0.00 (0.01)  0.01 (0.02) 
    Anxiety  0.00 (0.01)  0.02 (0.01)†  0.00 (0.01)  0.00 (0.01) -0.01 (0.01)†  0.01 (0.02) 
    Physical function  0.02 (0.01)*  0.04 (0.01)**  0.01 (0.00)**  0.01 (0.01)  0.00 (0.01)  0.02 (0.01)* 
Control 






 0.81 (0.04)** 
 





    Baseline PA  0.03 (0.03) n/a  0.01 (0.02)  0.38 (0.05)** n/a n/a 
    12 Month EF n/a n/a n/a n/a  0.46 (0.07)** -0.06 (0.10) 
    12 Month PA n/a n/a -0.01 (0.02) n/a  0.05 (0.03)*  0.69 (0.06)** 
    24 Month EF  0.12 (0.02)** n/a n/a n/a n/a n/a 
    24 Month PA n/a n/a n/a n/a -0.02 (0.02) n/a 
    Age -0.03 (0.01)** -0.02 (0.01)* -0.01 (0.00)†  0.00 (0.01) -0.02 (0.01)** -0.01 (0.01) 
    Education  0.05 (0.01)**  0.05 (0.03)†  0.00 (0.01) -0.04 (0.03)  0.04 (0.01)**  0.02 (0.03) 
    Fatigue -0.01 (0.01)  0.04 (0.01)*  0.00 (0.00)  0.00 (0.01)  0.01 (0.01)  0.01 (0.01) 
    Depression  0.00 (0.01)  0.01 (0.01) -0.01 (0.01) -0.03 (0.01)*  0.00 (0.01) -0.01 (0.02) 
    Anxiety -0.02 (0.01) -0.01 (0.01)  0.01 (0.00)  0.02 (0.01)  0.00 (0.01)  0.00 (0.01) 
    Physical function  0.00 (0.01)  0.02 (0.01)†  0.01 (0.00)†  0.01 (0.01) -0.01 (0.00)  0.00 (0.01) 
Note.  ARCL = autoregressive cross-lagged; EF = executive function; PA = physical activity; SE = standard error; BCS = Breast 
cancer survivor; n/a = not applicable. 
†p < 0.10.  
*p < 0.05.  
















Figure 2.  Study flowchart.  Unless they refused to continue study participation, participants who did not complete or partially 









Figure 3.  Auto-regressive cross-lagged model, grouped into breast cancer survivors (BCS) and 
controls.  Coefficients are standardized. 
†p < 0.10. 
*p < 0.05. 











Figure 4.  Auto-regressive cross-lagged model, grouped into breast cancer survivors (BCS) and 
controls.  Covariates included.  Coefficients are standardized. 
†p < 0.10. 
*p < 0.05. 












Figure 5.  Scatterplots with regression lines for physical activity over time by baseline physical 
function.  Time is in years. BCS = breast cancer survivors. LogMET =  Loge of Metabolic 







Figure 6.  Scatterplots with regression lines for executive function over time by baseline physical 
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